This is part of a larger prospective cohort study funded by European and Developing Countries Clinical Trial Partnership (EDCTP) entitled “Optimization of HIV and TB co-treatment based on pharmacokinetic and pharmacogenetic aspects of drug- drug interactions between rifampicin and efavirenz”.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}